Skip to main content
Livermore
Livermore
ZHEN

Daiwa Securities Group Inc.

SEC CIK
0001481045
Latest filing
Jul 31, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Daiwa Securities Group Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of CRSP by Daiwa Securities Group Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−1,449−100.0%Sold outHolders
Q4 20251,449$76.0K<0.1%−196−11.9%ReducedHolders
Q3 20251,645$107.0K<0.1%−155−8.6%ReducedHolders
Q2 20251,800$88.0K<0.1%+1,518+538.3%AddedHolders
Q1 2025282$10.0K<0.1%00.0%UnchangedHolders
Q4 2024282$11.0K<0.1%−45−13.8%ReducedHolders
Q3 2024327$15.0K<0.1%+30+10.1%AddedHolders
Q2 2024297$16.0K<0.1%−1,080−78.4%ReducedHolders
Q1 20241,377$94.0K<0.1%−88−6.0%ReducedHolders
Q4 20231,465$92.0K<0.1%−198−11.9%ReducedHolders
Q3 20231,663$75.0K<0.1%00.0%UnchangedHolders
Q2 20231,663$93.0K<0.1%+1,348+427.9%AddedHolders
Q1 2023315$14.0K<0.1%00.0%UnchangedHolders
Q4 2022315$13.0K<0.1%+26+9.0%AddedHolders
Q3 2022289$19.0K<0.1%00.0%UnchangedHolders
Q2 2022289$18.0K<0.1%−1,624−84.9%ReducedHolders
Q1 20221,913$120.0K<0.1%+530+38.3%AddedHolders
Q4 20211,383$105.0K<0.1%+548+65.6%AddedHolders
Q3 2021835$93.0K<0.1%+686+460.4%AddedHolders
Q2 2021149$24.0K<0.1%00.0%UnchangedHolders
Q1 2021149$18.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.